Systematic Review Writing for AMNOG & IQWiG HTA Submissions in Germany
In Germany, health technology assessment (HTA) submissions under AMNOG require rigorous evidence synthesis aligned with IQWiG methodology. A well-structured Systematic Review Writing process is not just an academic exercise—it directly influences reimbursement decisions, pricing negotiations, and benefit assessments. For pharmaceutical and biotech companies preparing dossiers for the Federal Joint Committee (G-BA), systematic reviews must meet stringent methodological standards, transparency requirements, and reproducibility expectations defined by IQWiG. This is where specialized expertise becomes essential. Why Systematic Review Writing Is Critical for AMNOG Submissions in Germany Under the AMNOG framework, manufacturers must demonstrate additional benefit over comparator therapies. Evidence gaps, methodological flaws, or incomplete reporting can lead to unfavorable benefit ratings and pricing outcomes. Professional Systematic Review Writing ensures: Structured PI...